Health Catalyst, Inc. (HCAT)
NASDAQ: HCAT · Real-Time Price · USD
1.460
-0.040 (-2.67%)
Nov 6, 2026, 4:00 PM EST - Market closed
Health Catalyst Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 272.21 | 311.14 | 306.58 | 295.94 | 276.24 | 241.93 | |
Revenue Growth | -13.88% | 1.49% | 3.60% | 7.13% | 14.18% | 28.11% |
Cost of Revenue | 137.45 | 156.5 | 164.79 | 161.11 | 140.68 | 124.17 |
Gross Profit | 134.76 | 154.63 | 141.79 | 134.83 | 135.56 | 117.76 |
Selling, General & Admin | 84.39 | 101.21 | 100.65 | 116.98 | 144.37 | 132.32 |
Research & Development | 38.48 | 46.09 | 56.8 | 68.5 | 69.23 | 61.83 |
Operating Expenses | 168.57 | 197.8 | 198.89 | 227.71 | 261.89 | 231.68 |
Operating Income | -33.81 | -43.17 | -57.1 | -92.88 | -126.33 | -113.92 |
Interest Expense | -20.83 | -24.25 | -17.09 | -7.17 | -1.68 | - |
Interest & Investment Income | 7.54 | 7.54 | 17.98 | - | - | - |
Other Non Operating Income (Expenses) | 0.32 | 0.32 | -0.26 | 16.27 | - | -16.46 |
EBT Excluding Unusual Items | -46.79 | -59.57 | -56.46 | -83.78 | -128.01 | -130.38 |
Merger & Restructuring Charges | -14.04 | -7.63 | -12.15 | -8.65 | -13.32 | -7.89 |
Impairment of Goodwill | -199.17 | -105.39 | - | - | - | - |
Asset Writedown | -4.84 | -11.74 | -2.2 | -4.08 | -5.02 | -1.8 |
Legal Settlements | - | - | - | -21.28 | - | - |
Other Unusual Items | -2.43 | 7.06 | 1.64 | - | 4.67 | -20.04 |
Pretax Income | -201.38 | -177.26 | -69.17 | -117.79 | -141.68 | -160.11 |
Income Tax Expense | 0.72 | 0.72 | 0.33 | 0.36 | -4.28 | -6.9 |
Earnings From Continuing Operations | - | -177.97 | -69.5 | -118.15 | -137.4 | -153.21 |
Net Income | -202.09 | -177.97 | -69.5 | -118.15 | -137.4 | -153.21 |
Net Income to Common | -202.09 | -177.97 | -69.5 | -118.15 | -137.4 | -153.21 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 73 | 70 | 60 | 56 | 54 | 47 |
Shares Outstanding (Diluted) | 73 | 70 | 60 | 56 | 54 | 47 |
Shares Change | 8.13% | 16.14% | 6.68% | 4.32% | 13.87% | 20.12% |
EPS (Basic) | -2.76 | -2.55 | -1.15 | -2.09 | -2.56 | -3.23 |
EPS (Diluted) | -2.76 | -2.55 | -1.15 | -2.09 | -2.63 | -3.23 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 25.71 | -0.24 | 12.94 | -34.32 | -37.44 | -33.57 |
Free Cash Flow Per Share | 0.35 | -0.00 | 0.21 | -0.61 | -0.69 | -0.71 |
Gross Margin | 49.51% | 49.70% | 46.25% | 45.56% | 49.07% | 48.68% |
Operating Margin | -12.42% | -13.87% | -18.62% | -31.39% | -45.73% | -47.09% |
Profit Margin | -74.24% | -57.20% | -22.67% | -39.92% | -49.74% | -63.33% |
Free Cash Flow Margin | 9.45% | -0.08% | 4.22% | -11.60% | -13.55% | -13.88% |
EBITDA | -0.61 | -5.17 | -25.37 | -59.16 | -84.83 | -78.79 |
EBITDA Margin | -0.22% | -1.66% | -8.27% | -19.99% | -30.71% | -32.57% |
D&A For EBITDA | 33.2 | 38 | 31.73 | 33.72 | 41.5 | 35.13 |
EBIT | -33.81 | -43.17 | -57.1 | -92.88 | -126.33 | -113.92 |
EBIT Margin | -12.42% | -13.87% | -18.62% | -31.39% | -45.73% | -47.09% |
Revenue as Reported | 272.21 | 311.14 | 306.58 | 295.94 | 276.24 | 241.93 |
Advertising Expenses | - | 3.1 | 5.1 | 2.6 | 5.7 | 4.4 |